series-c-plus
Stage
4
Investors
About
Redona Therapeutics discovers novel therapeutics targeting enzymes involved in the dysregulation of RNA and DNA processes implicated in serious diseases such as cancer and autoimmune disorders.
Explore Redona Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.